Q&A: Dennis Lo on the Origins and Future of Circulating Tumor DNA Detection

Key Points

• To explore the development of circulating tumor DNA detection and its impact on noninvasive testing for cancer.
• Discussion of the origin of noninvasive prenatal testing using fetal DNA.
• Exploration of the evolution of liquid biopsy techniques.
• Outlining new methodologies for analyzing circulating tumor DNA.
• Identification of fetal DNA in maternal blood led to breakthroughs in cancer detection.
• Advancements in liquid biopsy methods improve noninvasive cancer diagnostics.
• New techniques enhance the accuracy of detecting circulating tumor DNA.